Support program for individuals with early-stage memory loss living alone
Early-Stage Partner in Care-Living Alone (EPIC-LA)
This study is testing a support program for people aged 60 and older with early-stage memory loss who live alone, to see if it helps them feel better and manage their challenges through online group sessions and personalized support.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 70 (estimated) |
| Ages | 60 Years and up |
| Sex | All |
| Sponsor | Arizona State University Academic / other |
| Locations | 1 site (Phoenix, Arizona) |
| Trial ID | NCT06962111 on ClinicalTrials.gov |
What this trial studies
EPICLA+ is a program designed to assist individuals aged 60 and older with early-stage memory loss or dementia who live alone. The program offers education and skill-training sessions via Zoom to help participants manage challenges, reduce stress, and enhance their overall well-being. Participants will engage in group sessions, individualized support, and interviews to provide feedback and improve the program. The study aims to create a supportive community for those facing early-stage cognitive decline.
Who should consider this trial
Good fit: Ideal candidates for this program are individuals aged 60 and older who are experiencing early-stage dementia or mild cognitive impairment and live alone.
Not a fit: Patients who are unable to participate in online sessions or do not wish to engage in the program may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve the quality of life for patients with early-stage memory loss by providing them with essential coping strategies and social support.
How similar studies have performed: Other studies focusing on psychoeducational interventions for early-stage dementia have shown promise, indicating that this approach may be beneficial.
Eligibility criteria
Show full inclusion / exclusion criteria
Early-stage inclusion criteria 1. Must be at least 60 years of age 2. Must be able to participate in English or Spanish 3. Must be a US resident 4. Must be able to provide consent verbally and in writing (electronically or via mail) 5. Must exhibit at least 2 of 8 changes caused by thinking and memory problems on the AD8 (a reliable and valid 8-item dementia screening tool). 6. The Early-stage individual must have a diagnosis of early-stage ADRD or have a Mini-Mental State Exam (MMSE) score: 1. between 20-26 for those who have completed high school, or 2. between 17-26\*, for those who have not completed high school, or 3. 27 or higher with a confirmed diagnosis of early-stage dementia or MCI. 7. Able to participate in EPIC-LA workshops via zoom Exclusion Criteria: 8. Inability to participate via telephone or online video conferencing service. 9. The participant expresses feelings of not wanting to participate 10. The participant do not have enough time to attend the training, 11. The participant demonstrates lack of skills with using a computer that precludes participation 12. The participant does not have a stable internet connection to connect to the video platform 13. The participant has difficulty hearing or a visual impairment that precludes participation.
Where this trial is running
Phoenix, Arizona
- Arizona State University — Phoenix, Arizona, United States (Recruiting)
Study contacts
- Principal investigator: Dr. Gomez-Morales — Asu
- Study coordinator: Dr. Gomez-Morales, PhD
- Email: agomezm1@asu.edu
- Phone: 602-543-6672
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.